Skip to main content

3 Result(s)

within Kristof Cuppens Remove this filter

and

  1. Article

    Open Access

    Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

    Antibodies targeting the immune checkpoint molecules PD-1, PD-L1 and CTLA-4, administered alone or in combination with chemotherapy, are the standard of care in most patients with metastatic non-small-cell lun...

    Martin Schuler, Kristof Cuppens, Till Plönes, Marcel Wiesweg… in Nature Medicine (2024)

    Download PDF (7900 KB) View Article

  2. Article

    Open Access

    Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

    Treatment of patients with epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) continues to evolve expeditiously.

    Kristof Cuppens, Liesbet Lodewyckx, Ingel Demedts… in Drugs - Real World Outcomes (2021)

    Download PDF (790 KB) View Article

  3. No Access

    Article

    Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden

    Unplanned hospital admissions (UHAs) are frequent in lung cancer, but literature on this topic is scarce. The aim of this study is to gain insight in the demographics, patterns of referral, causes, presenting ...

    Kristof Cuppens, Christel Oyen, Aurélie Derweduwen… in Supportive Care in Cancer (2016)